These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21497449)

  • 1. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
    He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
    Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
    Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
    Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
    Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
    Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
    Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
    Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features.
    Ohta Y; Suzuki T; Hamatani S; Shiokawa A; Kushima M; Ota H
    Pathol Res Pract; 2008; 204(9):683-7. PubMed ID: 18462891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
    Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
    Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
    Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
    Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.
    Sugihara T; Nakagawa S; Sasajima Y; Matsumoto Y; Takeshita S; Ayabe T
    J Obstet Gynaecol Res; 2015 Mar; 41(3):483-7. PubMed ID: 25257165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synchronous mucinous metaplasia and neoplasia of the female genital tract].
    Gu WY; Tao X; Zhang LL; Wang L; Zhou XR; Ning Y
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):845-850. PubMed ID: 30423608
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
    Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
    Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
    Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
    Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
    Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
    Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
    Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
    Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box protein P1 is a useful marker for the diagnosis of mucinous minimal deviation adenocarcinoma of uterine cervix.
    Yang Q; Jiang W; Li L; Huang Q; Yang KX
    Ann Diagn Pathol; 2014 Aug; 18(4):232-7. PubMed ID: 24908370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.